Genmab — Juli 2016
-
Big Pharma og M&A - http://mobile.reuters.com/article/idUSKCN0ZZ0BG
-
Novartis har måske alligevel mere brug for nye stoffer end først antaget - når nu deres egne fejler
http://www.fiercebiotech.com/biotech/fda-rejects-novartis-biosim-app-for-amgen-blockbuster -
God observans, en anden mulighed kunne også være vanskeligheder med udviklingen. Han plejer ikke at være så afdæmpet, men måske journalisten bare er en tør rosin med støv på jakkesættet eller den hjemmestrikkede sweater. Men kunne godt tænkes der gødes, de får bare ikke mine.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind